Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.

× No keyword cloud information.

54 in total

Review 1. Antifibrinolytic Therapy and Perioperative Considerations.

Authors: Jerrold H Levy; Andreas Koster; Quintin J Quinones; Truman J Milling; Nigel S Key
Journal: Anesthesiology Date: 2018-03 Impact factor: 7.892

2. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

Authors: O Eriksson; H Kjellman; A Pilbrant; M Schannong
Journal: Eur J Clin Pharmacol Date: 1974-08-23 Impact factor: 2.953

3. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.

Authors: R Stagaard; M J Flick; B Bojko; K Goryński; P Z Goryńska; C D Ley; L H Olsen; T Knudsen
Journal: J Thromb Haemost Date: 2018-06-21 Impact factor: 5.824

4. Metabolism of fibrinogen in cirrhosis of the liver.

Authors: G N Tytgat; D Collen; M Verstraete
Journal: J Clin Invest Date: 1971-08 Impact factor: 14.808

5. Management of bleeding following major trauma: an updated European guideline.

Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn
Journal: Crit Care Date: 2010-04-06 Impact factor: 9.097

6. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

Authors: H Fodstad; I M Nilsson
Journal: Acta Neurochir (Wien) Date: 1981 Impact factor: 2.216

Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.

Review 1. Antifibrinolytic Therapy and Perioperative Considerations.

2. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

3. Abrogating fibrinolysis does not improve bleeding or rFVIIa/rFVIII treatment in a non-mucosal venous injury model in haemophilic rodents.

4. Metabolism of fibrinogen in cirrhosis of the liver.

5. Management of bleeding following major trauma: an updated European guideline.

6. Coagulation and fibrinolysis in blood and cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: effect of tranexamic acid (AMCA).

7. Metabolism of plasminogen in healthy subjects: effect of tranexamic acid.

8. Tranexamic acid and upper gastrointestinal haemorrhage--a double-blind trial.

9. Prevention of recurrence of spontaneous subarachnoid haemorrhage by tranexamic acid.

10. Population pharmacokinetics of tranexamic acid in paediatric patients undergoing craniosynostosis surgery.